The CD133


Journal

Frontiers in cellular and infection microbiology
ISSN: 2235-2988
Titre abrégé: Front Cell Infect Microbiol
Pays: Switzerland
ID NLM: 101585359

Informations de publication

Date de publication:
2020
Historique:
received: 27 03 2020
accepted: 20 08 2020
entrez: 26 10 2020
pubmed: 27 10 2020
medline: 22 6 2021
Statut: epublish

Résumé

Human milk is a significant source of different CD133

Identifiants

pubmed: 33102251
doi: 10.3389/fcimb.2020.546189
pmc: PMC7546783
doi:

Substances chimiques

AC133 Antigen 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

546189

Informations de copyright

Copyright © 2020 Valverde-Villegas, Naranjo-Gomez, Durand, Rutagwera, Bedin, Kankasa, Debiesse, Nagot, Tuaillon, Van de Perre and Molès.

Références

J Hematother Stem Cell Res. 2001 Oct;10(5):643-55
pubmed: 11672510
J Infect Dis. 2013 Jun 15;207(12):1807-16
pubmed: 23554378
J Hum Lact. 2020 May;36(2):303-309
pubmed: 31815589
J Virol. 1990 Feb;64(2):864-72
pubmed: 2296085
Nat Immunol. 2019 Jul;20(7):802-811
pubmed: 31213716
Baillieres Clin Haematol. 1995 Mar;8(1):113-30
pubmed: 7545035
J Acquir Immune Defic Syndr. 2016 Apr 15;71(5):467-73
pubmed: 26974413
Stem Cells. 2012 Oct;30(10):2164-74
pubmed: 22865647
Blood. 1992 May 15;79(10):2680-7
pubmed: 1375110
Arch Virol. 1994;137(1-2):1-23
pubmed: 7526824
Cell Host Microbe. 2011 Mar 17;9(3):223-234
pubmed: 21402361
Pediatr Allergy Immunol. 2018 Mar;29(2):133-143
pubmed: 29197124
Curr Opin Hematol. 2017 Jul;24(4):314-321
pubmed: 28375987
Cell Rep. 2018 Dec 26;25(13):3759-3773.e9
pubmed: 30590047
J Infect Dis. 1992 Oct;166(4):710-6
pubmed: 1382106
AIDS Res Hum Retroviruses. 2017 Jun;33(6):590-596
pubmed: 28125903
PLoS One. 2016 Jan 14;11(1):e0147460
pubmed: 26765684
J Hematother. 1996 Jun;5(3):213-26
pubmed: 8817388
Sci Transl Med. 2012 Jul 18;4(143):143sr3
pubmed: 22814853
Medicine (Baltimore). 2019 Nov;98(44):e17383
pubmed: 31689745
Nat Rev Immunol. 2017 Nov;17(11):729-1
pubmed: 28972205
Nat Rev Immunol. 2011 Sep 09;11(10):685-92
pubmed: 21904387
Cytotechnology. 2013 May;65(3):385-93
pubmed: 22940915
PLoS Pathog. 2017 Jul 21;13(7):e1006509
pubmed: 28732051
Cell. 2007 Nov 30;131(5):994-1008
pubmed: 18045540
Pediatr Res. 2017 Apr;81(4):556-564
pubmed: 27814344
Ann N Y Acad Sci. 1999 Apr 30;872:25-38; discussion 38-9
pubmed: 10372108
Thromb Res. 2013 Mar;131(3):238-43
pubmed: 23290306
Adv Exp Med Biol. 2013;777:99-111
pubmed: 23161078
Cell Adh Migr. 2012 Jan-Feb;6(1):39-48
pubmed: 22647939
Antivir Ther. 2012;17(3):557-63
pubmed: 22300770

Auteurs

Jacqueline María Valverde-Villegas (JM)

Pathogenesis and Control of Chronic Infections (PCCI), INSERM, University of Montpellier, Établissement Français du Sang, Montpellier, France.

Mar Naranjo-Gomez (M)

Pathogenesis and Control of Chronic Infections (PCCI), INSERM, University of Montpellier, Établissement Français du Sang, Montpellier, France.
IRMB, University of Montpellier, INSERM, CHU Montpellier, Montpellier, France.

Mélusine Durand (M)

Pathogenesis and Control of Chronic Infections (PCCI), INSERM, University of Montpellier, Établissement Français du Sang, Montpellier, France.

David Rutagwera (D)

Department of Paediatrics and Child Health, University Teaching Hospital, School of Medicine University of Zambia, Lusaka, Zambia.

Anne-Sophie Bedin (AS)

Pathogenesis and Control of Chronic Infections (PCCI), INSERM, University of Montpellier, Établissement Français du Sang, Montpellier, France.

Chipepo Kankasa (C)

Department of Paediatrics and Child Health, University Teaching Hospital, School of Medicine University of Zambia, Lusaka, Zambia.

Ségolène Debiesse (S)

Pathogenesis and Control of Chronic Infections (PCCI), INSERM, University of Montpellier, Établissement Français du Sang, Montpellier, France.

Nicolas Nagot (N)

Pathogenesis and Control of Chronic Infections (PCCI), INSERM, University of Montpellier, Établissement Français du Sang, Montpellier, France.
CHU Montpellier, Department of Bacteriology-Virology and Department of Medical Information, Montpellier, France.

Edouard Tuaillon (E)

Pathogenesis and Control of Chronic Infections (PCCI), INSERM, University of Montpellier, Établissement Français du Sang, Montpellier, France.
CHU Montpellier, Department of Bacteriology-Virology and Department of Medical Information, Montpellier, France.

Philippe Van de Perre (P)

Pathogenesis and Control of Chronic Infections (PCCI), INSERM, University of Montpellier, Établissement Français du Sang, Montpellier, France.
CHU Montpellier, Department of Bacteriology-Virology and Department of Medical Information, Montpellier, France.

Jean-Pierre Molès (JP)

Pathogenesis and Control of Chronic Infections (PCCI), INSERM, University of Montpellier, Établissement Français du Sang, Montpellier, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH